AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19288937 — intervention group
Group type: COMPARATOR
Intervention: Stentless group (27 patients)
Number of subjects: 38
Study 17291934 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 312
Study 17291934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 12875938 — intervention group
Group type: COMPARATOR
Intervention: Intrarectal lidocaine gel (10 cc of 2% lidocaine gel)
Number of subjects: 96
Study 12875938 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block (10 cc of 1% lidocaine solution injected under ultrasound guidance)
Number of subjects: 96
Study 10730921 — intervention group
Group type: EXPERIMENTAL
Intervention: Pear juice
Number of subjects: 39
Study 10730921 — intervention group
Group type: COMPARATOR
Intervention: Grape juice
Number of subjects: 39
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with DOX/DDP
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological response to neoadjuvant chemotherapy
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Change of chemotherapy for poor histological response
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose intensity with G-CSF
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporation of new agents like Ifosfamide
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Various drug administration methods
Number of subjects: 0
Study 9344323 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosen T10 protocol
Number of subjects: 0
Study 1314711 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of trivalent oral poliovirus vaccine (TOPV) at birth and subsequent doses at 2, 4, and 9 months of age (Group A)
Number of subjects: 85
Study 1314711 — intervention group
Group type: COMPARATOR
Intervention: One dose of trivalent oral poliovirus vaccine (TOPV) at 2, 4, and 6 months of age (Group B)
Number of subjects: 85
Study 3905062 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 686
Study 3905062 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 686
Study 31295854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 0
Study 31295854 — intervention group
Group type: EXPERIMENTAL
Intervention: Central European diet
Number of subjects: 0
Study 31295854 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher energy intake from fat
Number of subjects: 0
Study 31295854 — intervention group
Group type: EXPERIMENTAL
Intervention: GG IL6 rs1800795 genotype
Number of subjects: 0
Study 31295854 — intervention group
Group type: EXPERIMENTAL
Intervention: C-allele carriers of IL6 rs1800795
Number of subjects: 0
Study 31295854 — intervention group
Group type: COMPARATOR
Intervention: IL6 gene transcription levels and blood IL6 concentrations
Number of subjects: 0
Study 28145999 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 63
Study 28145999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 25900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.1 μg/kg/min infusion
Number of subjects: 90
Study 25900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg/min infusion
Number of subjects: 90
Study 23407306 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU/d)
Number of subjects: 35
Study 23407306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 21124330 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine (2 mg/day increased to 8 mg/day)
Number of subjects: 104
Study 21124330 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (2.5 mg/day increased to 10 mg/day)
Number of subjects: 104
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: MP plus thalidomide (MPT)
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: MP plus bortezomib (MPV)
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: MP plus lenalidomide or lenalidomide plus dexamethasone
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cyclophosphamide, thalidomide, and dexamethasone
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-intensity transplantation
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard MPT or MPV with reduced doses
Number of subjects: 5
Study 20008241 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate management of treatment-related adverse events
Number of subjects: 5
Study 17996133 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium magnesium aspartate
Number of subjects: 98
Study 17996133 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy for coronary heart disease (Control)
Number of subjects: 98
Study 15485433 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid 8‐mm‐tip catheter (group A, 65 degrees C, 70 W, 60 s)
Number of subjects: 130
Study 15485433 — intervention group
Group type: COMPARATOR
Intervention: Open irrigated‐tip catheter (group B, 65 degrees C, 50 W, 60 s, 17 mL/min flow)
Number of subjects: 130
Study 11508714 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace discrimination conditioning (500 ms)
Number of subjects: 0
Study 11508714 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace discrimination conditioning (1000 ms)
Number of subjects: 0
Study 11508714 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay discrimination conditioning (750 ms)
Number of subjects: 0
Study 11508714 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay discrimination conditioning (1250 ms)
Number of subjects: 0
Study 9704873 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide (450 mg/day)
Number of subjects: 124
Study 9704873 — intervention group
Group type: COMPARATOR
Intervention: clomipramine (150 mg/day)
Number of subjects: 124
Study 7626576 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral occlusion for 1 hour per day for 4 weeks
Number of subjects: 15
Study 7626576 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral occlusion for 4 hours per day for 4 weeks
Number of subjects: 15
Study 7626576 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral occlusion for 8 hours per day for 4 weeks
Number of subjects: 15
Study 2926470 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus cisplatin (CP)
Number of subjects: 349
Study 2926470 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide plus cisplatin plus doxorubicin (CAP)
Number of subjects: 349
Study 82680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day) for 3, 6, 9, or 12 months
Number of subjects: 96
Study 82680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day)
Number of subjects: 96
Study 82680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day) for 1 year
Number of subjects: 96
Study 31409579 — intervention group
Group type: EXPERIMENTAL
Intervention: NER1006 (1L polyethylene glycol)
Number of subjects: 1378
Study 31409579 — intervention group
Group type: COMPARATOR
Intervention: 2L polyethylene glycol + ascorbate (2LPEG)
Number of subjects: 1378
Study 31409579 — intervention group
Group type: COMPARATOR
Intervention: Oral sulfate solution (OSS)
Number of subjects: 1378
Study 27922948 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance
Number of subjects: 100
Study 27922948 — intervention group
Group type: COMPARATOR
Intervention: Loss of resistance with saline/air
Number of subjects: 100
Study 27922948 — intervention group
Group type: EXPERIMENTAL
Intervention: Correctly positioned thoracic epidural catheters
Number of subjects: 100
Study 27922948 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour morphine use
Number of subjects: 100
Study 27922948 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour numeric pain scores
Number of subjects: 100
Study 25524834 — intervention group
Group type: EXPERIMENTAL
Intervention: Boceprevir (BOC)
Number of subjects: 2288
Study 25524834 — intervention group
Group type: EXPERIMENTAL
Intervention: Telaprevir (TPV)
Number of subjects: 2288
Study 25524834 — intervention group
Group type: COMPARATOR
Intervention: PEG/RBV (Control)
Number of subjects: 2288
Study 23233710 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP plus rituximab (CHOP-R)
Number of subjects: 554
Study 23233710 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy plus iodine-131 tositumomab (CHOP-RIT)
Number of subjects: 554
Study 20933046 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant applied to alternate teeth
Number of subjects: 17
Study 20933046 — intervention group
Group type: COMPARATOR
Intervention: Control teeth (uncoated)
Number of subjects: 17
Study 20933046 — intervention group
Group type: COMPARATOR
Intervention: Comparison of sealed vs control teeth at final visit
Number of subjects: 17
Study 20141067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral internal sphincterotomy (group S)
Number of subjects: 160
Study 20141067 — intervention group
Group type: COMPARATOR
Intervention: Local diltiazem ointment (group D)
Number of subjects: 160
Study 20141067 — intervention group
Group type: COMPARATOR
Intervention: Local glyceryl trinitrate ointment (group GTN)
Number of subjects: 160
Study 20141067 — intervention group
Group type: COMPARATOR
Intervention: Injection of botulinum toxin (group BT)
Number of subjects: 160
Study 16769462 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 136
Study 16769462 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 136
Study 12945826 — intervention group
Group type: EXPERIMENTAL
Intervention: Coding by experienced dietitians using the same database and software package
Number of subjects: 52
Study 12945826 — intervention group
Group type: EXPERIMENTAL
Intervention: Coding by experienced dietitians
Number of subjects: 52
Study 12945826 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of nutrients (e.g., vitamin C, vitamin A, cholesterol)
Number of subjects: 52
Study 10532600 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusions if Hb < 8 g/dL or predetermined clinical conditions
Number of subjects: 428
Study 10532600 — intervention group
Group type: COMPARATOR
Intervention: Control group treated according to physician's orders (Hb < 9 g/dL)
Number of subjects: 428
Study 10532600 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 428
Study 8955546 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activation
Number of subjects: 60
Study 8955546 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest
Number of subjects: 60
Study 8955546 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depression
Number of subjects: 60
Study 8955546 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 1867151 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weeks of friendly staff telephone contact
Number of subjects: 0
Study 1867151 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 0
Study 1867151 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of staff contact
Number of subjects: 0
Study 1867151 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer telephone dyads
Number of subjects: 0
Study 7080769 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated chromatographic influenza vaccine A(H3N2)
Number of subjects: 152
Study 7080769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 3858877 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10)
Number of subjects: 0
Study 3858877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3858877 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 29308962 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 39
Study 29308962 — intervention group
Group type: COMPARATOR
Intervention: Control group (untaped patients)
Number of subjects: 39
Study 26510183 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Epidural Analgesia (PCEA)
Number of subjects: 120
Study 26510183 — intervention group
Group type: COMPARATOR
Intervention: Patient-Controlled Intravenous Analgesia (PCIA)
Number of subjects: 120
Study 24767719 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-day course of daily prednisolone therapy during an upper respiratory tract infection (URTI)
Number of subjects: 300
Study 24767719 — intervention group
Group type: COMPARATOR
Intervention: No change to current therapy (placebo)
Number of subjects: 300
Study 22002685 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfalfa (ALF)
Number of subjects: 20
Study 22002685 — intervention group
Group type: EXPERIMENTAL
Intervention: Birdsfoot trefoil (BFT)
Number of subjects: 20
Study 22002685 — intervention group
Group type: COMPARATOR
Intervention: Control (TF or RCG without ALF or BFT)
Number of subjects: 20
Study 20438325 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice beverage (CherryPharm, Inc.)
Number of subjects: 15
Study 20438325 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 15
Study 18519476 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 41
Study 18519476 — intervention group
Group type: COMPARATOR
Intervention: Room air (21% oxygen)
Number of subjects: 41
Study 15783019 — intervention group
Group type: EXPERIMENTAL
Intervention: Dai-kenchu-to (DKT) 5g administered orally three times a day
Number of subjects: 84
Study 15783019 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose 16g administered orally three times a day
Number of subjects: 84
Study 15783019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 84
Study 12689357 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar skin warming (42 degrees C, 20 min)
Number of subjects: 0
Study 12689357 — intervention group
Group type: COMPARATOR
Intervention: Time-matched control group without skin warming
Number of subjects: 0
Study 10532092 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg once daily
Number of subjects: 555
Study 10532092 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 0.5 mg once daily
Number of subjects: 555
Study 10532092 — intervention group
Group type: COMPARATOR
Intervention: Aminoglutethimide (AG) 250 mg twice daily with corticosteroid support
Number of subjects: 555
Study 8530996 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation not modified and local tranexamic acid applied during and after surgery
Number of subjects: 92
Study 8530996 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulation reduced and calcium heparin added preoperatively
Number of subjects: 92
Study 1991755 — intervention group
Group type: EXPERIMENTAL
Intervention: Hansson pin technique
Number of subjects: 115
Study 1991755 — intervention group
Group type: COMPARATOR
Intervention: Uppsala screw technique
Number of subjects: 115
Study 7113711 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg (D)
Number of subjects: 32
Study 7113711 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.5 g/kg (A)
Number of subjects: 32
Study 7113711 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg (D) + Alcohol 0.5 g/kg (A)
Number of subjects: 32
Study 7113711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31239180 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered consultations
Number of subjects: 97
Study 31239180 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 97
Study 29417169 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA (transepicondylar axis)
Number of subjects: 48
Study 29417169 — intervention group
Group type: COMPARATOR
Intervention: PoCoLi (posterior condylar line)
Number of subjects: 48
Study 27903924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (20 mg/m2, increased to 25 mg/m2 for subsequent cycles if tolerated)
Number of subjects: 101
Study 27903924 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (40 mg/m2/week)
Number of subjects: 101
Study 27903924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 101
Study 27903924 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 101
Study 24468015 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole augmentation
Number of subjects: 14
Study 22607512 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid fine-needle biopsy (FNB)
Number of subjects: 110
Study 20403951 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltapaq coil (Micrus Endovascular)
Number of subjects: 15
Study 20403951 — intervention group
Group type: COMPARATOR
Intervention: Helipaq coil (Micrus)
Number of subjects: 15
Study 20403951 — intervention group
Group type: COMPARATOR
Intervention: Ultipaq coil (Micrus)
Number of subjects: 15
Study 18575944 — intervention group
Group type: EXPERIMENTAL
Intervention: Autograft hamstring tendon constructs
Number of subjects: 84
Study 18575944 — intervention group
Group type: COMPARATOR
Intervention: Allograft constructs
Number of subjects: 84
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and cyclophosphamide (AC)
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxanes
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose dense chemotherapy incorporating AC and paclitaxel
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (T)
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 0
Study 16205597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian suppression combined with an AI
Number of subjects: 0
Study 12122630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and tobramycin with dexamethasone
Number of subjects: 80
Study 12122630 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin and tobramycin without dexamethasone
Number of subjects: 80
Study 10368248 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day frequency-volume (FV) chart
Number of subjects: 23
Study 10368248 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 men, mean age 63.3 years, range 58‐69)
Number of subjects: 23
Study 8901799 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour milk (Calpis), 95 mL daily for 8 weeks
Number of subjects: 30
Study 8901799 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificially acidified milk), 95 mL daily for 8 weeks
Number of subjects: 30
Study 1812906 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised brushing program (at least 70% compliance)
Number of subjects: 2415
Study 1812906 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised brushing program
Number of subjects: 2415
Study 1812906 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fluoride dentifrice (1,500 ppm F MFP)
Number of subjects: 2415
Study 6848468 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (n = 50)
Number of subjects: 150
Study 6848468 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (n = 50)
Number of subjects: 150
Study 6848468 — intervention group
Group type: COMPARATOR
Intervention: Midrange blood pressure comparison group (n = 50)
Number of subjects: 150
Study 29480175 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability (VVV) in blood pressure (BP)
Number of subjects: 2305
Study 26541103 — intervention group
Group type: EXPERIMENTAL
Intervention: Central air injection
Number of subjects: 48
Study 26541103 — intervention group
Group type: COMPARATOR
Intervention: Peripheral air injection
Number of subjects: 48
Study 24630347 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral fat supplement and fish oil
Number of subjects: 36
Study 24630347 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 36
Study 22705237 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecounseling (7 sessions over 12 weeks)
Number of subjects: 40
Study 22705237 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 40
Study 19821068 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation (ALP) applied to the left forearms of BD patients
Number of subjects: 35
Study 19821068 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin pathergy test (SPT) performed on both forearms of BD patients
Number of subjects: 35
Study 17698733 — intervention group
Group type: EXPERIMENTAL
Intervention: cTnT assay (detection limit < or = 0.01 ng/mL)
Number of subjects: 4053
Study 17698733 — intervention group
Group type: EXPERIMENTAL
Intervention: hsTnT assay (detection limit < or = 0.001 ng/mL)
Number of subjects: 4053
Study 17698733 — intervention group
Group type: EXPERIMENTAL
Intervention: hsTnT assay added to models adjusted for clinical risk factors
Number of subjects: 4053
Study 15694874 — intervention group
Group type: EXPERIMENTAL
Intervention: Forgiveness-related constructs assessment
Number of subjects: 61
Study 15694874 — intervention group
Group type: EXPERIMENTAL
Intervention: State anger mediation analysis
Number of subjects: 61
Study 12192353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup (10 mg/kg 3 times a day for 5 days)
Number of subjects: 36
Study 12192353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 12192353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup
Number of subjects: 36
Study 10665199 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐oral fluoride releasing device (IFRD) releasing 0.04 mg/day of fluoride for 12 months
Number of subjects: 76
Study 10665199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride device)
Number of subjects: 76